Join our study for a new treatment for a type of blood cancer, Acute Myeloid Leukemia (AML) with a specific mutation called FLT3. We are looking for older adults who have recently been diagnosed and who may not be fit for intense treatments. The study involves testing a combination of medicines to see if they help. This study looks at two ways to treat AML. We will compare the usual treatment with Azacitidine and Venetoclax to adding a new medicine called Gilteritinib to them.
You will have a check-up, heart test, blood tests, and a bone marrow test. You will also fill out some questionnaires.
Breast Imaging Center
NC Women's Hospital
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Joshua Zeidner
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Leukemia)
25-0948
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
